These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1429727)

  • 1. Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure.
    Blasquez VC; Hale MA; Trevorrow KW; Garrard WT
    J Biol Chem; 1992 Nov; 267(33):23888-93. PubMed ID: 1429727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin kappa gene expression after stable integration. I. Role of the intronic MAR and enhancer in plasmacytoma cells.
    Blasquez VC; Xu M; Moses SC; Garrard WT
    J Biol Chem; 1989 Dec; 264(35):21183-9. PubMed ID: 2512290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin kappa gene expression after stable integration. II. Role of the intronic MAR and enhancer in transgenic mice.
    Xu M; Hammer RE; Blasquez VC; Jones SL; Garrard WT
    J Biol Chem; 1989 Dec; 264(35):21190-5. PubMed ID: 2512291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
    Fulton R; van Ness B
    Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
    Mautner J; Behrends U; Hörtnagel K; Brielmeier M; Hammerschmidt W; Strobl L; Bornkamm GW; Polack A
    Oncogene; 1996 Mar; 12(6):1299-307. PubMed ID: 8649832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
    Fulton R; Van Ness B
    Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin structural analyses of the mouse Igkappa gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer.
    Liu ZM; George-Raizen JB; Li S; Meyers KC; Chang MY; Garrard WT
    J Biol Chem; 2002 Sep; 277(36):32640-9. PubMed ID: 12080064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinant differences between the rabbit and mouse immunoglobulin kappa enhancers impair the activity of the rabbit enhancer in mouse myeloma cells.
    Akimenko MA; Ekker M; Doyen N; Biben C; Rougeon F
    Nucleic Acids Res; 1989 Jun; 17(12):4745-55. PubMed ID: 2501761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNase I-hypersensitive sites in the chromatin of immunoglobulin kappa light chain genes.
    Chung SY; Folsom V; Wooley J
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2427-31. PubMed ID: 6221340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.
    Nikolajczyk BS; Sardi SH; Tumang JR; Ganley-Leal LM
    Mol Immunol; 2007 Jul; 44(13):3407-15. PubMed ID: 17382392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated.
    Kelley DE; Pollok BA; Atchison ML; Perry RP
    Mol Cell Biol; 1988 Feb; 8(2):930-7. PubMed ID: 3127693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunoglobulin kappa gene enhancer: chromatin structure analysis at high resolution.
    Gimble JM; Max EE
    Mol Cell Biol; 1987 Jan; 7(1):15-25. PubMed ID: 3031454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
    Liu Z; Garrard WT
    Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin structures of the rat tyrosine aminotransferase gene relate to the function of its cis-acting elements.
    Nitsch D; Stewart AF; Boshart M; Mestril R; Weih F; Schütz G
    Mol Cell Biol; 1990 Jul; 10(7):3334-42. PubMed ID: 1972541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
    Pongubala JM; Atchison ML
    Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.